Why the study?
Does diphenylhydantoin reduce premature ventricular contractions in patients with non-digitalis-induced ventricular ectopic rhythms?
Does diphenylhydantoin reduce premature ventricular contractions in patients with non-digitalis-induced ventricular ectopic rhythms?
Diphenylhydantoin effectively reduces premature ventricular contractions in patients with non-digitalis-induced ventricular ectopic rhythms.
May support diphenylhydantoin for non-digitalis ventricular ectopy; hypothesis-generating and requires randomized confirmation.
For the treatment of non-digitalis-induced ventricular ectopic rhythms, the effect of diphenylhydantoin was studied in 5 patients and compared with the effect of placebo in 5 control patients. For the first three weeks the dosage of diphenylhydantoin was 100 mg four times daily. Then, for maintenance therapy during the rest of the three-month study, the dosage was reduced to 100 mg three times daily. The numbers of premature ventricular contractions during a five-minute continuous ECG monitoring period were recorded before therapy, after three weeks of therapy, and after three months of therapy. There was a marked reduction in the number of ventricular ectopic beats in the diphenylhydantoin group compared with the control group.
No takes yet. Share an insight, caveat, or question.
George L. Kemp (1972) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: